{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:55:30Z","timestamp":1790808930790,"version":"4.1.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,20]]},"DOI":"10.7759\/cureus.56583","type":"journal-article","created":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T18:32:23Z","timestamp":1710959543000},"source":"Crossref","is-referenced-by-count":26,"title":["Advancements in Pancreatic Cancer Detection: Integrating Biomarkers, Imaging Technologies, and Machine Learning for Early Diagnosis"],"prefix":"10.7759","author":[{"given":"Hisham","family":"Daher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sneha A","family":"Punchayil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amro Ahmed Elbeltagi","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reuben Ryan","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohab H","family":"Algazzar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1609\/aimag.v27i4.1904","article-title":"A proposal for the Dartmouth Summer Research Project on artificial intelligence","volume":"24","author":"McCarthy J","year":"1955","unstructured":"McCarthy J, Minsky ML, Rochester N, Shannon CE. A proposal for the Dartmouth Summer Research Project on artificial intelligence. AI Mag. 1955, 24:12. 10.1609\/aimag.v27i4.1904","journal-title":"AI Mag"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4103\/ijc.IJC_399_20","article-title":"Artificial intelligence in cancer diagnostics and therapy: current perspectives","volume":"58","author":"Majumder A","year":"2021","unstructured":"Majumder A, Sen D. Artificial intelligence in cancer diagnostics and therapy: current perspectives. Indian J Cancer. 2021, 58:481-92. 10.4103\/ijc.IJC_399_20","journal-title":"Indian J Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12012","article-title":"Emerging role of deep learning-based artificial intelligence in tumor pathology","volume":"40","author":"Jiang Y","year":"2020","unstructured":"Jiang Y, Yang M, Wang S, Li X, Sun Y. Emerging role of deep learning-based artificial intelligence in tumor pathology. Cancer Commun (Lond). 2020, 40:154-66. 10.1002\/cac2.12012","journal-title":"Cancer Commun (Lond)"},{"key":"ref4","article-title":"The global burden of breast cancer in women","author":"Soerjomataram I","year":"2019","unstructured":"Soerjomataram I, Allemani C, Voogd A, Siesling S. The global burden of breast cancer in women. Breast Cancer: Global Quality Care. Verhoeven D, Kaufman C, Mansel R, Siesling S (ed): Oxford University Press, Oxford, UK; 2019. 2:3-C1.P41."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay J","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, et al.. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015, 136:E359-86. 10.1002\/ijc.29210","journal-title":"Int J Cancer"},{"key":"ref6","unstructured":"SEER Cancer Statistics Review (CSR) 1975-2016. (2020). Accessed. March 19, 2024: https:\/\/seer.cancer.gov\/archive\/csr\/1975_2016\/index.html."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2018.12.001","article-title":"A systematic assessment of statistics, risk factors, and underlying features involved in pancreatic cancer","volume":"58","author":"Aier I","year":"2019","unstructured":"Aier I, Semwal R, Sharma A, Varadwaj PK. A systematic assessment of statistics, risk factors, and underlying features involved in pancreatic cancer. Cancer Epidemiol. 2019, 58:104-10. 10.1016\/j.canep.2018.12.001","journal-title":"Cancer Epidemiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.18063\/ghl.v2i1.243","article-title":"Pancreatic cancer-current situation and challenges","volume":"24","author":"Jin C","year":"2020","unstructured":"Jin C, Bai L. Pancreatic cancer-current situation and challenges. Gastroenterol Hepatol Lett. 2020, 24:1-3. 10.18063\/ghl.v2i1.243","journal-title":"Gastroenterol Hepatol Lett"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e3181613142","article-title":"Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?","volume":"247","author":"Schnelldorfer T","year":"2008","unstructured":"Schnelldorfer T, Ware AL, Sarr MG, et al.. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?. Ann Surg. 2008, 247:456-62. 10.1097\/SLA.0b013e3181613142","journal-title":"Ann Surg"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00298","article-title":"The multicenter Cancer of Pancreas Screening study: impact on stage and survival","volume":"40","author":"Dbouk M","year":"2022","unstructured":"Dbouk M, Katona BW, Brand RE, et al.. The multicenter Cancer of Pancreas Screening study: impact on stage and survival. J Clin Oncol. 2022, 40:3257-66. 10.1200\/JCO.22.00298","journal-title":"J Clin Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-018175","article-title":"Comparing the diagnostic accuracy of five common tumour biomarkers and CA19-9 for pancreatic cancer: a protocol for a network meta-analysis of diagnostic test accuracy","volume":"7","author":"Ge L","year":"2017","unstructured":"Ge L, Pan B, Song F, Ma J, Zeraatkar D, Zhou J, Tian J. Comparing the diagnostic accuracy of five common tumour biomarkers and CA19-9 for pancreatic cancer: a protocol for a network meta-analysis of diagnostic test accuracy. BMJ Open. 2017, 7:e018175. 10.1136\/bmjopen-2017-018175","journal-title":"BMJ Open"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2019.11192","article-title":"Evaluation of circulating cell-free DNA as a molecular monitoring tool in patients with metastatic cancer","volume":"19","author":"Hufnagl C","year":"2020","unstructured":"Hufnagl C, Leisch M, Weiss L, et al.. Evaluation of circulating cell-free DNA as a molecular monitoring tool in patients with metastatic cancer. Oncol Lett. 2020, 19:1551-8. 10.3892\/ol.2019.11192","journal-title":"Oncol Lett"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.24","article-title":"Exploiting inflammation for therapeutic gain in pancreatic cancer","volume":"108","author":"Steele CW","year":"2013","unstructured":"Steele CW, Jamieson NB, Evans TR, McKay CJ, Sansom OJ, Morton JP, Carter CR. Exploiting inflammation for therapeutic gain in pancreatic cancer. Br J Cancer. 2013, 108:997-1003. 10.1038\/bjc.2013.24","journal-title":"Br J Cancer"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.hpb.2017.11.009","article-title":"Systematic review on the role of serum tumor markers in the detection of recurrent pancreatic cancer","volume":"20","author":"Daamen LA","year":"2018","unstructured":"Daamen LA, Groot VP, Heerkens HD, Intven MP, van Santvoort HC, Molenaar IQ. Systematic review on the role of serum tumor markers in the detection of recurrent pancreatic cancer. HPB (Oxford). 2018, 20:297-304. 10.1016\/j.hpb.2017.11.009","journal-title":"HPB (Oxford)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2017.05.023","article-title":"B7-H4 is a prognostic biomarker for poor survival in patients with pancreatic cancer","volume":"66","author":"Shen L","year":"2017","unstructured":"Shen L, Qian Y, Wu W, et al.. B7-H4 is a prognostic biomarker for poor survival in patients with pancreatic cancer. Hum Pathol. 2017, 66:79-85. 10.1016\/j.humpath.2017.05.023","journal-title":"Hum Pathol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0000000000000956","article-title":"The effect of pancreatic juice collection time on the detection of KRAS mutations","volume":"47","author":"Suenaga M","year":"2018","unstructured":"Suenaga M, Dudley B, Karloski E, Borges M, Irene Canto M, Brand RE, Goggins M. The effect of pancreatic juice collection time on the detection of KRAS mutations. Pancreas. 2018, 47:35-9. 10.1097\/MPA.0000000000000956","journal-title":"Pancreas"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00194","article-title":"Pancreatic cancer surveillance in carriers of a germline CDKN2A pathogenic variant: yield and outcomes of a 20-year prospective follow-up","volume":"40","author":"Klatte DC","year":"2022","unstructured":"Klatte DC, Boekestijn B, Wasser MN, et al.. Pancreatic cancer surveillance in carriers of a germline CDKN2A pathogenic variant: yield and outcomes of a 20-year prospective follow-up. J Clin Oncol. 2022, 40:3267-77. 10.1200\/JCO.22.00194","journal-title":"J Clin Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(19)30416-9","article-title":"Early detection of pancreatic cancer","volume":"5","author":"Pereira SP","year":"2020","unstructured":"Pereira SP, Oldfield L, Ney A, et al.. Early detection of pancreatic cancer. Lancet Gastroenterol Hepatol. 2020, 5:698-710. 10.1016\/S2468-1253(19)30416-9","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/95.3.214","article-title":"BRCA2 germline mutations in familial pancreatic carcinoma","volume":"95","author":"Hahn SA","year":"2003","unstructured":"Hahn SA, Greenhalf B, Ellis I, et al.. BRCA2 germline mutations in familial pancreatic carcinoma. J Natl Cancer Inst. 2003, 95:214-21. 10.1093\/jnci\/95.3.214","journal-title":"J Natl Cancer Inst"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-019-0426-5","article-title":"Family history of cancer, Ashkenazi Jewish ancestry, and pancreatic cancer risk","volume":"120","author":"Hamada T","year":"2019","unstructured":"Hamada T, Yuan C, Yurgelun MB, et al.. Family history of cancer, Ashkenazi Jewish ancestry, and pancreatic cancer risk. Br J Cancer. 2019, 120:848-54. 10.1038\/s41416-019-0426-5","journal-title":"Br J Cancer"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1159\/000159214","article-title":"International registries of families at high risk of pancreatic cancer","volume":"8","author":"Greenhalf W","year":"2008","unstructured":"Greenhalf W, Malats N, Nilsson M, Bartsch D, Neoptolemos J. International registries of families at high risk of pancreatic cancer. Pancreatology. 2008, 8:558-65. 10.1159\/000159214","journal-title":"Pancreatology"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/s41395-018-0395-y","article-title":"Identification of cystic lesions by secondary screening of familial pancreatic cancer (FPC) kindreds is not associated with the stratified risk of cancer","volume":"114","author":"Sheel AR","year":"2019","unstructured":"Sheel AR, Harrison S, Sarantitis I, et al.. Identification of cystic lesions by secondary screening of familial pancreatic cancer (FPC) kindreds is not associated with the stratified risk of cancer. Am J Gastroenterol. 2019, 114:155-64. 10.1038\/s41395-018-0395-y","journal-title":"Am J Gastroenterol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2011.03.003","article-title":"Diabetes mellitus and risk of pancreatic cancer: a meta-analysis of cohort studies","volume":"47","author":"Ben Q","year":"2011","unstructured":"Ben Q, Xu M, Ning X, et al.. Diabetes mellitus and risk of pancreatic cancer: a meta-analysis of cohort studies. Eur J Cancer. 2011, 47:1928-37. 10.1016\/j.ejca.2011.03.003","journal-title":"Eur J Cancer"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0b013e31822a27db","article-title":"Multicenter study of serous cystic neoplasm of the Japan pancreas society","volume":"41","author":"Kimura W","year":"2012","unstructured":"Kimura W, Moriya T, Hirai I, et al.. Multicenter study of serous cystic neoplasm of the Japan pancreas society. Pancreas. 2012, 41:380-7. 10.1097\/MPA.0b013e31822a27db","journal-title":"Pancreas"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2012.190","article-title":"The risk of pancreatic cancer in symptomatic patients in primary care: a large case-control study using electronic records","volume":"106","author":"Stapley S","year":"2012","unstructured":"Stapley S, Peters TJ, Neal RD, Rose PW, Walter FM, Hamilton W. The risk of pancreatic cancer in symptomatic patients in primary care: a large case-control study using electronic records. Br J Cancer. 2012, 106:1940-4. 10.1038\/bjc.2012.190","journal-title":"Br J Cancer"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-019-02290-y","article-title":"White paper on pancreatic ductal adenocarcinoma from Society of Abdominal Radiology's disease-focused panel for pancreatic ductal adenocarcinoma: part II, update on imaging techniques and screening of pancreatic cancer in high-risk individuals","volume":"45","author":"Kulkarni NM","year":"2020","unstructured":"Kulkarni NM, Mannelli L, Zins M, et al.. White paper on pancreatic ductal adenocarcinoma from Society of Abdominal Radiology's disease-focused panel for pancreatic ductal adenocarcinoma: part II, update on imaging techniques and screening of pancreatic cancer in high-risk individuals. Abdom Radiol (NY). 2020, 45:729-42. 10.1007\/s00261-019-02290-y","journal-title":"Abdom Radiol (NY)"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.22.27859","article-title":"Standardization of MRI screening and reporting in individuals with elevated risk of pancreatic ductal adenocarcinoma: consensus statement of the PRECEDE Consortium","volume":"219","author":"Huang C","year":"2022","unstructured":"Huang C, Simeone DM, Luk L, et al.. Standardization of MRI screening and reporting in individuals with elevated risk of pancreatic ductal adenocarcinoma: consensus statement of the PRECEDE Consortium. AJR Am J Roentgenol. 2022, 219:903-14. 10.2214\/AJR.22.27859","journal-title":"AJR Am J Roentgenol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-019-06564-3","article-title":"Deep learning: definition and perspectives for thoracic imaging","volume":"30","author":"Chassagnon G","year":"2020","unstructured":"Chassagnon G, Vakalopolou M, Paragios N, Revel MP. Deep learning: definition and perspectives for thoracic imaging. Eur Radiol. 2020, 30:2021-30. 10.1007\/s00330-019-06564-3","journal-title":"Eur Radiol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.diii.2020.10.001","article-title":"A primer for understanding radiology articles about machine learning and deep learning","volume":"101","author":"Nakaura T","year":"2020","unstructured":"Nakaura T, Higaki T, Awai K, Ikeda O, Yamashita Y. A primer for understanding radiology articles about machine learning and deep learning. Diagn Interv Imaging. 2020, 101:765-70. 10.1016\/j.diii.2020.10.001","journal-title":"Diagn Interv Imaging"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-020-07376-6","article-title":"Pancreas image mining: a systematic review of radiomics","volume":"31","author":"Abunahel BM","year":"2021","unstructured":"Abunahel BM, Pontre B, Kumar H, Petrov MS. Pancreas image mining: a systematic review of radiomics. Eur Radiol. 2021, 31:3447-67. 10.1007\/s00330-020-07376-6","journal-title":"Eur Radiol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-019-1426-2","article-title":"Key challenges for delivering clinical impact with artificial intelligence","volume":"17","author":"Kelly CJ","year":"2019","unstructured":"Kelly CJ, Karthikesalingam A, Suleyman M, Corrado G, King D. Key challenges for delivering clinical impact with artificial intelligence. BMC Med. 2019, 17:195. 10.1186\/s12916-019-1426-2","journal-title":"BMC Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-020-06946-y","article-title":"Implementation of artificial intelligence (AI) applications in radiology: hindering and facilitating factors","volume":"30","author":"Strohm L","year":"2020","unstructured":"Strohm L, Hehakaya C, Ranschaert ER, Boon WP, Moors EH. Implementation of artificial intelligence (AI) applications in radiology: hindering and facilitating factors. Eur Radiol. 2020, 30:5525-32. 10.1007\/s00330-020-06946-y","journal-title":"Eur Radiol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.molonc.2012.01.010","article-title":"Cancer biomarkers","volume":"6","author":"Henry NL","year":"2012","unstructured":"Henry NL, Hayes DF. Cancer biomarkers. Mol Oncol. 2012, 6:140-6. 10.1016\/j.molonc.2012.01.010","journal-title":"Mol Oncol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.4103\/jcrt.jcrt_384_22","article-title":"The issues and challenges with cancer biomarkers","volume":"19","author":"Purkayastha K","year":"2023","unstructured":"Purkayastha K, Dhar R, Pethusamy K, Srivastava T, Shankar A, Rath GK, Karmakar S. The issues and challenges with cancer biomarkers. J Cancer Res Ther. 2023, 19:S20-35. 10.4103\/jcrt.jcrt_384_22","journal-title":"J Cancer Res Ther"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2018.00108","article-title":"Identification and validation of a diagnostic and prognostic multi-gene biomarker panel for pancreatic ductal adenocarcinoma","volume":"9","author":"Klett H","year":"2018","unstructured":"Klett H, Fuellgraf H, Levit-Zerdoun E, et al.. Identification and validation of a diagnostic and prognostic multi-gene biomarker panel for pancreatic ductal adenocarcinoma. Front Genet. 2018, 9:108. 10.3389\/fgene.2018.00108","journal-title":"Front Genet"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.7150\/thno.77949","article-title":"Artificial intelligence in pancreatic cancer","volume":"12","author":"Huang B","year":"2022","unstructured":"Huang B, Huang H, Zhang S, Zhang D, Shi Q, Liu J, Guo J. Artificial intelligence in pancreatic cancer. Theranostics. 2022, 12:6931-54. 10.7150\/thno.77949","journal-title":"Theranostics"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12071965","article-title":"Use of biomarkers and imaging for early detection of pancreatic cancer","volume":"12","author":"Kato S","year":"2020","unstructured":"Kato S, Honda K. Use of biomarkers and imaging for early detection of pancreatic cancer. Cancers (Basel). 2020, 12:4-6. 10.3390\/cancers12071965","journal-title":"Cancers (Basel)"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1101\/gr.124347.111","article-title":"Translational genomics: the challenge of developing cancer biomarkers","volume":"22","author":"Brooks JD","year":"2012","unstructured":"Brooks JD. Translational genomics: the challenge of developing cancer biomarkers. Genome Res. 2012, 22:183-7. 10.1101\/gr.124347.111","journal-title":"Genome Res"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112488","article-title":"Current advances in prognostic and diagnostic biomarkers for solid cancers: detection techniques and future challenges","volume":"146","author":"Pal M","year":"2022","unstructured":"Pal M, Muinao T, Boruah HP, Mahindroo N. Current advances in prognostic and diagnostic biomarkers for solid cancers: detection techniques and future challenges. Biomed Pharmacother. 2022, 146:112488. 10.1016\/j.biopha.2021.112488","journal-title":"Biomed Pharmacother"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15112928","article-title":"The role of artificial intelligence in the detection and implementation of biomarkers for hepatocellular carcinoma: outlook and opportunities","volume":"15","author":"Mansur A","year":"2023","unstructured":"Mansur A, Vrionis A, Charles JP, et al.. The role of artificial intelligence in the detection and implementation of biomarkers for hepatocellular carcinoma: outlook and opportunities. Cancers (Basel). 2023, 15:24-6. 10.3390\/cancers15112928","journal-title":"Cancers (Basel)"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.01306","article-title":"Identification of platform-independent diagnostic biomarker panel for hepatocellular carcinoma using large-scale transcriptomics data","volume":"10","author":"Kaur H","year":"2019","unstructured":"Kaur H, Dhall A, Kumar R, Raghava GP. Identification of platform-independent diagnostic biomarker panel for hepatocellular carcinoma using large-scale transcriptomics data. Front Genet. 2019, 10:1306. 10.3389\/fgene.2019.01306","journal-title":"Front Genet"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.mex.2023.102021","article-title":"Detection of key mRNAs in liver tissue of hepatocellular carcinoma patients based on machine learning and bioinformatics analysis","volume":"10","author":"Gholizadeh M","year":"2023","unstructured":"Gholizadeh M, Mazlooman SR, Hadizadeh M, Drozdzik M, Eslami S. Detection of key mRNAs in liver tissue of hepatocellular carcinoma patients based on machine learning and bioinformatics analysis. MethodsX. 2023, 10:102021. 10.1016\/j.mex.2023.102021","journal-title":"MethodsX"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.2196\/19812","article-title":"Predicting hepatocellular carcinoma with minimal features from electronic health records: development of a deep learning model","volume":"7","author":"Liang CW","year":"2021","unstructured":"Liang CW, Yang HC, Islam MM, et al.. Predicting hepatocellular carcinoma with minimal features from electronic health records: development of a deep learning model. JMIR Cancer. 2021, 7:e19812. 10.2196\/19812","journal-title":"JMIR Cancer"},{"key":"ref44","article-title":"Artificial intelligence based on serum biomarkers predicts the efficacy of lenvatinib for unresectable hepatocellular carcinoma","volume":"15","author":"Hsu PY","year":"2022","unstructured":"Hsu PY, Liang PC, Chang WT, et al.. Artificial intelligence based on serum biomarkers predicts the efficacy of lenvatinib for unresectable hepatocellular carcinoma. Am J Cancer Res. 2022, 15:5576-88.","journal-title":"Am J Cancer Res"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.2144\/fsoa-2021-0074","article-title":"An overview of artificial intelligence in oncology","volume":"8","author":"Farina E","year":"2022","unstructured":"Farina E, Nabhen JJ, Dacoregio MI, Batalini F, Moraes FY. An overview of artificial intelligence in oncology. Future Sci OA. 2022, 8:FSO787. 10.2144\/fsoa-2021-0074","journal-title":"Future Sci OA"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3313","article-title":"A multianalyte panel consisting of extracellular vesicle miRNAs and mRNAs, cfDNA, and CA19-9 shows utility for diagnosis and staging of pancreatic ductal adenocarcinoma","volume":"26","author":"Yang Z","year":"2020","unstructured":"Yang Z, LaRiviere MJ, Ko J, et al.. A multianalyte panel consisting of extracellular vesicle miRNAs and mRNAs, cfDNA, and CA19-9 shows utility for diagnosis and staging of pancreatic ductal adenocarcinoma. Clin Cancer Res. 2020, 26:3248-58. 10.1158\/1078-0432.CCR-19-3313","journal-title":"Clin Cancer Res"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-021-02955-7","article-title":"Multi-institutional development and external validation of machine learning-based models to predict relapse risk of pancreatic ductal adenocarcinoma after radical resection","volume":"19","author":"Li X","year":"2021","unstructured":"Li X, Yang L, Yuan Z, et al.. Multi-institutional development and external validation of machine learning-based models to predict relapse risk of pancreatic ductal adenocarcinoma after radical resection. J Transl Med. 2021, 19:281. 10.1186\/s12967-021-02955-7","journal-title":"J Transl Med"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i24.7864","article-title":"Imaging diagnosis of pancreatic cancer: a state-of-the-art review","volume":"20","author":"Lee ES","year":"2014","unstructured":"Lee ES, Lee JM. Imaging diagnosis of pancreatic cancer: a state-of-the-art review. World J Gastroenterol. 2014, 20:7864-77. 10.3748\/wjg.v20.i24.7864","journal-title":"World J Gastroenterol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1080\/13651820500540949","article-title":"Diagnosis of pancreatic cancer","volume":"8","author":"Miura F","year":"2006","unstructured":"Miura F, Takada T, Amano H, Yoshida M, Furui S, Takeshita K. Diagnosis of pancreatic cancer. HPB (Oxford). 2006, 8:337-42. 10.1080\/13651820500540949","journal-title":"HPB (Oxford)"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2243011284","article-title":"Isoattenuating pancreatic adenocarcinoma at multi-detector row CT: secondary signs","volume":"224","author":"Prokesch RW","year":"2002","unstructured":"Prokesch RW, Chow LC, Beaulieu CF, Bammer R, Jeffrey RB Jr. Isoattenuating pancreatic adenocarcinoma at multi-detector row CT: secondary signs. Radiology. 2002, 224:764-8. 10.1148\/radiol.2243011284","journal-title":"Radiology"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.199.3.8637990","article-title":"Two-phase helical CT for pancreatic tumors: pancreatic versus hepatic phase enhancement of tumor, pancreas, and vascular structures","volume":"199","author":"Lu DS","year":"1996","unstructured":"Lu DS, Vedantham S, Krasny RM, Kadell B, Berger WL, Reber HA. Two-phase helical CT for pancreatic tumors: pancreatic versus hepatic phase enhancement of tumor, pancreas, and vascular structures. Radiology. 1996, 199:697-701. 10.1148\/radiology.199.3.8637990","journal-title":"Radiology"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.213.1.r99oc25107","article-title":"Abdominal US for diagnosis of pancreatic tumor: prospective cohort analysis","volume":"213","author":"Karlson BM","year":"1999","unstructured":"Karlson BM, Ekbom A, Lindgren PG, K\u00e4llskog V, Rastad J. Abdominal US for diagnosis of pancreatic tumor: prospective cohort analysis. Radiology. 1999, 213:107-11. 10.1148\/radiology.213.1.r99oc25107","journal-title":"Radiology"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.190.3.8115622","article-title":"Pancreatic tumors: evaluation with endoscopic US, CT, and MR imaging","volume":"190","author":"M\u00fcller MF","year":"1994","unstructured":"M\u00fcller MF, Meyenberger C, Bertschinger P, Schaer R, Marincek B. Pancreatic tumors: evaluation with endoscopic US, CT, and MR imaging. Radiology. 1994, 190:745-51. 10.1148\/radiology.190.3.8115622","journal-title":"Radiology"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.183.1.1312736","article-title":"Adenocarcinoma of the pancreatic ducts: comparative evaluation with CT and MR imaging at 1.5 T","volume":"183","author":"Vellet AD","year":"1992","unstructured":"Vellet AD, Romano W, Bach DB, Passi RB, Taves DH, Munk PL. Adenocarcinoma of the pancreatic ducts: comparative evaluation with CT and MR imaging at 1.5 T. Radiology. 1992, 183:87-95. 10.1148\/radiology.183.1.1312736","journal-title":"Radiology"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.193.3.7972808","article-title":"Small pancreatic adenocarcinomas: efficacy of MR imaging with fat suppression and gadolinium enhancement","volume":"193","author":"Gabata T","year":"1994","unstructured":"Gabata T, Matsui O, Kadoya M, et al.. Small pancreatic adenocarcinomas: efficacy of MR imaging with fat suppression and gadolinium enhancement. Radiology. 1994, 193:683-8. 10.1148\/radiology.193.3.7972808","journal-title":"Radiology"},{"key":"ref56","doi-asserted-by":"crossref","DOI":"10.1002\/(SICI)1097-0142(19970215)79:4<695::AID-CNCR6>3.0.CO;2-D","article-title":"18F-fluorodeoxyglucose positron emission tomography and the prognosis of patients with pancreatic adenocarcinoma","volume":"79","author":"Nakata B","year":"1997","unstructured":"Nakata B, Chung YS, Nishimura S, et al.. 18F-fluorodeoxyglucose positron emission tomography and the prognosis of patients with pancreatic adenocarcinoma. Cancer. 1997, 79:695-9.","journal-title":"Cancer"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-015-0557-y","article-title":"Common and uncommon pitfalls in pancreatic imaging: it is not always cancer","volume":"41","author":"Vernuccio F","year":"2016","unstructured":"Vernuccio F, Borhani AA, Dioguardi Burgio M, Midiri M, Furlan A, Brancatelli G. Common and uncommon pitfalls in pancreatic imaging: it is not always cancer. Abdom Radiol (NY). 2016, 41:283-94. 10.1007\/s00261-015-0557-y","journal-title":"Abdom Radiol (NY)"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1102\/1470-7330.2013.9012","article-title":"Mimics of pancreatic ductal adenocarcinoma","volume":"13","author":"Al-Hawary MM","year":"2013","unstructured":"Al-Hawary MM, Kaza RK, Azar SF, Ruma JA, Francis IR. Mimics of pancreatic ductal adenocarcinoma. Cancer Imaging. 2013, 13:342-9. 10.1102\/1470-7330.2013.9012","journal-title":"Cancer Imaging"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.060137","article-title":"Artificial intelligence for contrast-free MRI: scar assessment in myocardial infarction using deep learning-based virtual native enhancement","volume":"146","author":"Zhang Q","year":"2022","unstructured":"Zhang Q, Burrage MK, Shanmuganathan M, et al.. Artificial intelligence for contrast-free MRI: scar assessment in myocardial infarction using deep learning-based virtual native enhancement. Circulation. 2022, 146:1492-503. 10.1161\/CIRCULATIONAHA.122.060137","journal-title":"Circulation"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02625-9","article-title":"Prospective implementation of AI-assisted screen reading to improve early detection of breast cancer","volume":"29","author":"Ng AY","year":"2023","unstructured":"Ng AY, Oberije CJ, Ambr\u00f3zay \u00c9, et al.. Prospective implementation of AI-assisted screen reading to improve early detection of breast cancer. Nat Med. 2023, 29:3044-9. 10.1038\/s41591-023-02625-9","journal-title":"Nat Med"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.1095","article-title":"Development and validation of a deep learning-based automated detection algorithm for major thoracic diseases on chest radiographs","volume":"2","author":"Hwang EJ","year":"2019","unstructured":"Hwang EJ, Park S, Jin KN, et al.. Development and validation of a deep learning-based automated detection algorithm for major thoracic diseases on chest radiographs. JAMA Netw Open. 2019, 2:e191095. 10.1001\/jamanetworkopen.2019.1095","journal-title":"JAMA Netw Open"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000000544","article-title":"Establishment and application of an artificial intelligence diagnosis system for pancreatic cancer with a faster region-based convolutional neural network","volume":"132","author":"Liu SL","year":"2019","unstructured":"Liu SL, Li S, Guo YT, Zhou YP, Zhang ZD, Li S, Lu Y. Establishment and application of an artificial intelligence diagnosis system for pancreatic cancer with a faster region-based convolutional neural network. Chin Med J (Engl). 2019, 132:2795-803. 10.1097\/CM9.0000000000000544","journal-title":"Chin Med J (Engl)"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.3389\/frai.2019.00002","article-title":"Pancreatic cancer prediction through an artificial neural network","volume":"2","author":"Muhammad W","year":"2019","unstructured":"Muhammad W, Hart GR, Nartowt B, Farrell JJ, Johung K, Liang Y, Deng J. Pancreatic cancer prediction through an artificial neural network. Front Artif Intell. 2019, 2:2. 10.3389\/frai.2019.00002","journal-title":"Front Artif Intell"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1002\/jhbp.825","article-title":"Deep learning analysis for the detection of pancreatic cancer on endosonographic images: a pilot study","volume":"28","author":"Tonozuka R","year":"2021","unstructured":"Tonozuka R, Itoi T, Nagata N, et al.. Deep learning analysis for the detection of pancreatic cancer on endosonographic images: a pilot study. J Hepatobiliary Pancreat Sci. 2021, 28:95-104. 10.1002\/jhbp.825","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"ref65","article-title":"Knowledge bases in medicine: a review","volume":"78","author":"Perry CA","year":"1990","unstructured":"Perry CA. Knowledge bases in medicine: a review. Bull Med Libr Assoc. 1990, 78:271-82.","journal-title":"Bull Med Libr Assoc"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12822","article-title":"eDoctor: machine learning and the future of medicine","volume":"284","author":"Handelman GS","year":"2018","unstructured":"Handelman GS, Kok HK, Chandra RV, Razavi AH, Lee MJ, Asadi H. eDoctor: machine learning and the future of medicine. J Intern Med. 2018, 284:603-19. 10.1111\/joim.12822","journal-title":"J Intern Med"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-021-00407-0","article-title":"A guide to machine learning for biologists","volume":"23","author":"Greener JG","year":"2022","unstructured":"Greener JG, Kandathil SM, Moffat L, Jones DT. A guide to machine learning for biologists. Nat Rev Mol Cell Biol. 2022, 23:40-55. 10.1038\/s41580-021-00407-0","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1186\/s12911-019-1004-8","article-title":"Comparing different supervised machine learning algorithms for disease prediction","volume":"19","author":"Uddin S","year":"2019","unstructured":"Uddin S, Khan A, Hossain ME, Moni MA. Comparing different supervised machine learning algorithms for disease prediction. BMC Med Inform Decis Mak. 2019, 19:281. 10.1186\/s12911-019-1004-8","journal-title":"BMC Med Inform Decis Mak"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajodo.2023.04.001","article-title":"Unsupervised learning","volume":"163","author":"Valkenborg D","year":"2023","unstructured":"Valkenborg D, Rousseau AJ, Geubbelmans M, Burzykowski T. Unsupervised learning. Am J Orthod Dentofacial Orthop. 2023, 163:877-82. 10.1016\/j.ajodo.2023.04.001","journal-title":"Am J Orthod Dentofacial Orthop"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.49560","article-title":"The utility of artificial intelligence in the diagnosis and management of pancreatic cancer","volume":"15","author":"Kumar V","year":"2023","unstructured":"Kumar V, Gaddam M, Moustafa A, et al.. The utility of artificial intelligence in the diagnosis and management of pancreatic cancer. Cureus. 2023, 15:e49560. 10.7759\/cureus.49560","journal-title":"Cureus"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.21037\/cco-21-117","article-title":"Artificial intelligence and imaging for risk prediction of pancreatic cancer: a narrative review","volume":"11","author":"Qureshi TA","year":"2022","unstructured":"Qureshi TA, Javed S, Sarmadi T, Pandol SJ, Li D. Artificial intelligence and imaging for risk prediction of pancreatic cancer: a narrative review. Chin Clin Oncol. 2022, 11:1. 10.21037\/cco-21-117","journal-title":"Chin Clin Oncol"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12134209","article-title":"Computer-aided detection for pancreatic cancer diagnosis: radiological challenges and future directions","volume":"12","author":"Ramaekers M","year":"2023","unstructured":"Ramaekers M, Viviers CG, Janssen BV, et al.. Computer-aided detection for pancreatic cancer diagnosis: radiological challenges and future directions. J Clin Med. 2023, 12:4-6. 10.3390\/jcm12134209","journal-title":"J Clin Med"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1016\/j.patrec.2005.10.010","article-title":"An introduction to ROC analysis","volume":"27","author":"Fawcett T","year":"2006","unstructured":"Fawcett T. An introduction to ROC analysis. Pattern Recogn Lett. 2006, 27:861-74. 10.1016\/j.patrec.2005.10.010","journal-title":"Pattern Recogn Lett"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.3390\/math9222970","article-title":"Machine learning (ML) in medicine: review, applications, and challenges","volume":"9","author":"Rahmani AM","year":"2021","unstructured":"Rahmani AM, Yousefpoor E, Yousefpoor MS, Mehmood Z, Haider A, Hosseinzadeh M, Naqvi RA. Machine learning (ML) in medicine: review, applications, and challenges. Mathematics. 2021, 9:2970. 10.3390\/math9222970","journal-title":"Mathematics"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2020.10.019","article-title":"Development and validation of a pancreatic cancer risk model for the general population using electronic health records: an observational study","volume":"143","author":"Appelbaum L","year":"2021","unstructured":"Appelbaum L, Cambronero JP, Stevens JP, et al.. Development and validation of a pancreatic cancer risk model for the general population using electronic health records: an observational study. Eur J Cancer. 2021, 143:19-30. 10.1016\/j.ejca.2020.10.019","journal-title":"Eur J Cancer"},{"key":"ref76","article-title":"A deep-learning based prediction of pancreatic adenocarcinoma with electronic health records from the state of Maine","volume":"14","author":"Li X","year":"2007","unstructured":"Li X, Gao P, Huang C, et al.. A deep-learning based prediction of pancreatic adenocarcinoma with electronic health records from the state of Maine. Int J Med Health Sci. 2007, 14:358-65.","journal-title":"Int J Med Health Sci"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1200\/CCI.20.00137","article-title":"Clinical data prediction model to identify patients with early-stage pancreatic cancer","volume":"5","author":"Chen Q","year":"2021","unstructured":"Chen Q, Cherry DR, Nalawade V, et al.. Clinical data prediction model to identify patients with early-stage pancreatic cancer. JCO Clin Cancer Inform. 2021, 5:279-87. 10.1200\/CCI.20.00137","journal-title":"JCO Clin Cancer Inform"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2021.39.3_suppl.394","article-title":"Development of a pancreatic cancer prediction model using a multinational medical records database","volume":"39","author":"Appelbaum L","year":"2021","unstructured":"Appelbaum L, Berg A, Cambronero JP, et al.. Development of a pancreatic cancer prediction model using a multinational medical records database. J Clin Oncol. 2021, 39:394-4. 10.1200\/JCO.2021.39.3_suppl.394","journal-title":"J Clin Oncol"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2021.03.016","article-title":"Quality gaps in public pancreas imaging datasets: implications & challenges for AI applications","volume":"21","author":"Suman G","year":"2021","unstructured":"Suman G, Patra A, Korfiatis P, et al.. Quality gaps in public pancreas imaging datasets: implications &amp; challenges for AI applications. Pancreatology. 2021, 21:1001-8. 10.1016\/j.pan.2021.03.016","journal-title":"Pancreatology"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.633176","article-title":"Understanding Sources of Variation to Improve the Reproducibility of Radiomics","volume":"11","author":"Zhao B","year":"2021","unstructured":"Zhao B. Understanding Sources of Variation to Improve the Reproducibility of Radiomics. Front Oncol. 2021, 11:633176. 10.3389\/fonc.2021.633176","journal-title":"Front Oncol"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-019-06381-8","article-title":"Radiomic feature reproducibility in contrast-enhanced CT of the pancreas is affected by variabilities in scan parameters and manual segmentation","volume":"30","author":"Yamashita R","year":"2020","unstructured":"Yamashita R, Perrin T, Chakraborty J, et al.. Radiomic feature reproducibility in contrast-enhanced CT of the pancreas is affected by variabilities in scan parameters and manual segmentation. Eur Radiol. 2020, 30:195-205. 10.1007\/s00330-019-06381-8","journal-title":"Eur Radiol"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.3348\/kjr.2018.0070","article-title":"Reproducibility and generalizability in radiomics modeling: possible strategies in radiologic and statistical perspectives","volume":"20","author":"Park JE","year":"2019","unstructured":"Park JE, Park SY, Kim HJ, Kim HS. Reproducibility and generalizability in radiomics modeling: possible strategies in radiologic and statistical perspectives. Korean J Radiol. 2019, 20:1124-37. 10.3348\/kjr.2018.0070","journal-title":"Korean J Radiol"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-022-00496-w","article-title":"Validation and real-world clinical application of an artificial intelligence algorithm for breast cancer detection in biopsies","volume":"8","author":"Sandbank J","year":"2022","unstructured":"Sandbank J, Bataillon G, Nudelman A, et al.. Validation and real-world clinical application of an artificial intelligence algorithm for breast cancer detection in biopsies. NPJ Breast Cancer. 2022, 8:129. 10.1038\/s41523-022-00496-w","journal-title":"NPJ Breast Cancer"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.3389\/frai.2022.879603","article-title":"Transparency of AI in healthcare as a multilayered system of accountabilities: between legal requirements and technical limitations","volume":"5","author":"Kiseleva A","year":"2022","unstructured":"Kiseleva A, Kotzinos D, De Hert P. Transparency of AI in healthcare as a multilayered system of accountabilities: between legal requirements and technical limitations. Front Artif Intell. 2022, 5:879603. 10.3389\/frai.2022.879603","journal-title":"Front Artif Intell"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1080\/17453674.2019.1682850","article-title":"AI ethics, accountability, and sustainability: revisiting the Hippocratic oath","volume":"91","author":"Fell\u00e4nder-Tsai L","year":"2020","unstructured":"Fell\u00e4nder-Tsai L. AI ethics, accountability, and sustainability: revisiting the Hippocratic oath. Acta Orthop. 2020, 91:1-2. 10.1080\/17453674.2019.1682850","journal-title":"Acta Orthop"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000036671","article-title":"Ethical implications of AI and robotics in healthcare: a review","volume":"102","author":"Elendu C","year":"2023","unstructured":"Elendu C, Amaechi DC, Elendu TC, et al.. Ethical implications of AI and robotics in healthcare: a review. Medicine (Baltimore). 2023, 102:e36671. 10.1097\/MD.0000000000036671","journal-title":"Medicine (Baltimore)"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1177\/0024363920922690","article-title":"Patient data-sharing for AI: ethical challenges, Catholic solutions","volume":"87","author":"Baric-Parker J","year":"2020","unstructured":"Baric-Parker J, Anderson EE. Patient data-sharing for AI: ethical challenges, Catholic solutions. Linacre Q. 2020, 87:471-81. 10.1177\/0024363920922690","journal-title":"Linacre Q"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1007\/s00146-020-01085-w","article-title":"Artificial intelligence in medicine and the disclosure of risks","volume":"36","author":"Kiener M","year":"2021","unstructured":"Kiener M. Artificial intelligence in medicine and the disclosure of risks. AI Soc. 2021, 36:705-13. 10.1007\/s00146-020-01085-w","journal-title":"AI Soc"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1186\/s42444-022-00075-x","article-title":"Clinical significance, challenges and limitations in using artificial intelligence for electrocardiography-based diagnosis","volume":"23","author":"Chung CT","year":"2022","unstructured":"Chung CT, Lee S, King E, Liu T, Armoundas AA, Bazoukis G, Tse G. Clinical significance, challenges and limitations in using artificial intelligence for electrocardiography-based diagnosis. Int J Arrhythmia. 2022, 23:24. 10.1186\/s42444-022-00075-x","journal-title":"Int J Arrhythmia"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2019.4917","article-title":"Artificial intelligence and surgical decision-making","volume":"155","author":"Loftus TJ","year":"2020","unstructured":"Loftus TJ, Tighe PJ, Filiberto AC, et al.. Artificial intelligence and surgical decision-making. JAMA Surg. 2020, 155:148-58. 10.1001\/jamasurg.2019.4917","journal-title":"JAMA Surg"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1097\/APO.0000000000000397","article-title":"Ethics of artificial intelligence in medicine and ophthalmology","volume":"10","author":"Abdullah YI","year":"2021","unstructured":"Abdullah YI, Schuman JS, Shabsigh R, Caplan A, Al-Aswad LA. Ethics of artificial intelligence in medicine and ophthalmology. Asia Pac J Ophthalmol (Phila). 2021, 10:289-98. 10.1097\/APO.0000000000000397","journal-title":"Asia Pac J Ophthalmol (Phila)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/226386-advancements-in-pancreatic-cancer-detection-integrating-biomarkers-imaging-technologies-and-machine-learning-for-early-diagnosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T18:32:30Z","timestamp":1710959550000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/226386-advancements-in-pancreatic-cancer-detection-integrating-biomarkers-imaging-technologies-and-machine-learning-for-early-diagnosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,20]]},"references-count":91,"URL":"https:\/\/doi.org\/10.7759\/cureus.56583","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,20]]}}}